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Background: While strong and consistent evidence supports the role of lifestyle modification in the prevention
and management of type 2 diabetes (T2DM), the best strategies for program implementation to support lifestyle
modification within primary care remain to be determined. The objective of the study is to evaluate the
implementation of an evidence-based self- management program for patients with T2DM within a newly
established primary care network (PCN) environment.
Method: Using a non-randomized design, participants (total N = 110 per group) will be consecutively allocated in
bi-monthly blocks to either a 6-month self-management program lead by an Exercise Specialist or to usual care.
Our primary outcome is self-reported physical activity and pedometer steps.
Discussion: The present study will assess whether a diabetes self-management program lead by an Exercise
Specialist provided within a newly emerging model of primary care and linked to available community-based
resources, can lead to positive changes in self-management behaviours for adults with T2DM. Ultimately, our work
will serve as a platform upon which an emerging model of primary care can incorporate effective and efficient
chronic disease management practices that are sustainable through partnerships with local community partners.
Clinical Trials Registration: ClinicalTrials.gov identifier: NCT00991380
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Globally, 346 million people have diabetes and the
prevalence of type 2 diabetes mellitus (T2DM) is
expected to increase to an estimated 440 million in the
next 20 years [1,2]. Consequently, treating and managing
this population will be a substantial burden to health
care systems [3]. There is, however, sufficient evidence
to suggest that drug treatment, physical activity (PA),
medical nutrition therapy, and body weight management
can mitigate longer-term complications of diabetes [2]
and thus potentially lessen the impending public health* Correspondence: sjohnson@athabascau.ca
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reproduction in any medium, provided the orburden. Healthy eating and active living are two main
ingredients of T2DM self-management. Attention to
both nutrition and physical activity (exercise) has repeat-
edly and consistently been shown to be associated with
improvements in metabolic risk [4-7]. As such, guide-
lines for healthy eating and active living have been devel-
oped for use in clinical practice [2,8]. Despite the
availability of evidence-based guidelines, the majority of
adults with T2DM follow unhealthy dietary patterns and
are insufficiently active [9,10] suggesting current front-
line approaches to promoting and supporting healthy
self-management may not be effective or efficient. Sev-
eral community-based or ‘real world’ interventions have
demonstrated that self-management programs can be ef-
fective in improving behavioral and clinical outcomesl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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success, questions still remain around the longer-term
impacts of these interventions at the patient level and at
the system level (i.e., primary care setting). More specif-
ically, if patient exposure needs to be increased (i.e.,
program intensity) to sustain shifts towards positive self-
management behaviours seen in what might be consid-
ered the early stages of adoption (e.g., 3 months), what
are the longer-term costs within the context of sustain-
ability for the patient and, at the same time, within the
context of program delivery?
Acknowledging that gaps still exist in terms of our
understanding of real world exemplars of diabetes self-
management delivered in primary care, we designed the
Healthy Eating and Active Living for Diabetes in Pri-
mary Care Networks (HEALD-PCN) study to explore
questions around the effectiveness and efficiency of
delivering an evidence-based self-management program
linked with community resources within in a newly
emerging model of primary care. We intend to develop
a comprehensive understanding of the system require-
ments for implementation, which will in turn provide
supportive evidence to inform policy makers with re-
spect to resource allocation and the potential for pro-
gram sustainability.
The main objective of HEALD-PCN is to evaluate a
novel implementation of an evidence- based self-
management program for patients identified as having
T2DM within an established Primary Care Network en-
vironment in Alberta, Canada. The primary study hy-
pothesis is that those allocated to HEALD-PCN program
will self-report higher levels of moderate and vigorous
physical activity and objectively monitored daily pedom-
eter steps. Secondary objectives are to complete a com-
prehensive evaluation to understand why the program
did or did not have an impact, identify critical factors to
successful implementation and to develop recommenda-
tions to mitigate barriers to successful implementation if
the intervention proves effective.
Methods/design
Ethical approval
All study procedures received approval from the Univer-
sity of Alberta Health Research Ethics Board prior to
study commencement. All participants provided written
informed consent.
Setting & population
This research will be carried out in four non-urban
Primary Care Networks (PCNs) in Alberta, Canada. All
PCNs are stand-alone physician-led corporations estab-
lished to support family physicians through allied profes-
sionals, including: Chronic Disease Management Nurses,
Registered Dietitian, Pharmacists, Health Promotion andPrevention Coordinators and Exercise Specialists.
According to the Alberta Diabetes Surveillance System,
the prevalence of diabetes in the province of Alberta was
5.5% in 2009 with approximately 20% over the age of 65
[17]. In the four participating PCNs, approximately
9,000 adult patients with diabetes are under the care of
approximately 140 General Practitioners.
All PCNs in the current study provide some form of
basic diabetes group education either through a group-
based workshop or one-on-one counseling with a Regis-
tered Dietitian and/or Exercise Specialist by physician
referral. It is recognized, however that these approaches
to support lifestyle self-management are most likely in-
sufficient to achieve and maintain lifestyle changes in
the longer term. Thus, the HEALD program is intended
to be an enhanced follow-up behavioral support pro-
gram, prescribed for patients who have already received
some form of basic diabetes self-management education.
The HEALD-PCN evaluation will be over and above the
baseline self-management education through a prag-
matic controlled trial [18].
Study subjects & recruitment
To satisfy the main objectives and achieve the study
aims, we propose to implement and evaluate the
HEALD program among recently diagnosed patients
who are cared for within the PCN environment. One
component of the PCNs management structure was the
development of a chronic disease patient registry. More
generally, a unique PCN patient registry will include in-
formation about the patient’s medical management and
allow physicians and PCN staff to track patient progress.
In keeping with the primary care network patient
chronic disease management strategy (i.e., tracking), po-
tentially eligible patients will be identified and recruited
through a patient registry.
Following identification of potential study partici-
pants through each participating PCN, an endorse-
ment letter from each PCN will be mailed to the
potential participant by staff located at each PCN.
Staff with this research responsibility within each of
the PCN environments is intended to simulate real
world chronic disease management practices (i.e., re-
cruitment to available PCN programs). The endorse-
ment letter was selected as a recruitment option after
consultation with the PCN chronic disease management
teams as a means to create a credible link between the
PCN and their clients. Those interested in the study
will be asked to contact the PCN by telephone where
they will be prescreened to further determine eligibility.
For those who have not responded by telephone within
a specified time, a PCN staff member will perform a
follow up phone call to determine interest and eligibil-
ity. Once an individual is deemed eligible, they will be
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mation sheet endorsed by the local PCN physician lead
for chronic disease management, a consent form and a
pedometer with instructions. A baseline appointment
will then be made with a trained Exercise Specialist to
collect all relevant baseline clinical/laboratory informa-
tion at each centralized PCN location using point-of-
care instruments.
Inclusion criteria
 On primary care patient registry (i.e., under PCN
physician care);
 18-75 years of age or who are capable of sustained
walking for 10 minutes;
 Diagnosed with type 2 diabetes (self-reported and
confirmed through PCN patient registry);
 Received basic diabetes education since being
diagnosed;
 Proficient English language skills.
Exclusion criteria
 Unable to provide informed consent or unwilling to
participate in the study;
 Unable to read, understand, and converse in English;
 Significant cardiovascular contraindications
(self-reported history when prompted);
 Significant current depression (self-reported) Patient
Health Questionnaire-9;
 Currently enrolled in any other study.
Patient allocation
Patients will be allocated to a control group (i.e., usual
care) or the intervention group using an “On-Off” group
assignment method (Figure 1) This method has been pre-
viously used in quality improvement studies [19-21], and
meets study design quality criteria to permit inclusion in
the Cochrane Collaborations’ Effective Practice and
Organization of Care (EPOC) systematic reviews [22].
Conceptually, eligible PCN patients will enter a “recruit-
ment pool” then allocated to the intervention or control
group in sequential clusters. This recruitment cluster will
be filled through a number of strategies, with an aim of 50
participants at a time. The first strategy will be through ac-
tive identification of newly diagnosed patients on each of
the PCN’s diabetes patient registry. It is recognized that
not all newly diagnosed patients will be immediately iden-
tified through this registry and therefore as a second strat-
egy, we will recruit newly diagnosed patients through
other PCN referral registries (i.e., patients attending basic
diabetes education classes). Newly diagnosed patients will
be given priority entry into the intervention since they
may be more likely to adopt new behaviours versus those
having diabetes for a longer period of time.Cut-point dates will be set to stop filling the recruit-
ment pool over a two-month time frame (i.e., bi-
monthly block). If the recruitment cluster fails to fill
with newly diagnosed patients (i.e., less than 50 eligible),
a third strategy for recruitment will be implemented
which will have the remaining program invitation spots
randomly selected from a second pool of patients who
were contacted through an earlier pre-screen mail out to
all diabetic patients on the PCN patient registry.
HEALD-PCN intervention
The HEALD-PCN intervention is based on a previously
pilot-tested self-management program in this patient
population [23]. It consists of two phases, lasting a total
of 24 weeks, with emphasis on physical activity (walking)
and nutritional elements. During weeks 1 to 12 (phase
1), participants allocated to the intervention group will
be placed in a self-monitored, pedometer-based walking
program targeting total daily steps. With initial guidance
from an Exercise Specialist, each participant will set his
or her own daily step goals. A baseline average will be
calculated from three consecutive days including one
weekend day [23-25] to help participants set individua-
lized goals. The program goal for all participants over
the first 12 weeks (phase 1) will be to increase their
number of steps/day.
As part of phase 1, during weeks 1 and 2, participants
will attend a 30-minute, group-based meeting, including
a supervised walking session, facilitated by the Exercise
Specialist, and located at a community recreation facility.
A pedometer, a resource manual and step logbook will
be provided at the first meeting to facilitate goal setting
and to record the total number of steps/day. Access to
the community recreation facility is based on partner-
ship arrangements between the research team, the PCN
and the local recreation facility management. Financial
arrangements for these agreements are provided by the
research funding. After week 12 (phase 2), participants
will be asked to continue to walk the same number of
steps/day that they walked during weeks 10-12 of phase
1. As part of phase 2, during weeks 13 and 14 partici-
pants will attend two more group-based meetings at the
same community recreation facility, where they will be
taught by the PCN Exercise Specialist how to increase
their walking speed by 10% during a 30 minute walk.
The participants will be asked to incorporate this faster
walking pace for 30 minutes/day on 3 days/week on
their own, until the end of the study period. For ex-
ample, if a participants’ self-selected walking pace was
90 steps/minute, they will be encouraged to increase his
or hers’ pace to approximately 100 steps/minute. Partici-
pants will be asked to perform their faster walking in
bouts lasting no less than 10 minutes, and will be given
a second pedometer and a stopwatch to help them
Figure 1 Study flow diagram.
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ond resource manual will be given to accompany this
part of the program, which will include a set of small
portable cards to record the number of brisk steps im-
mediately after they are performed.
The nutritional element of the HEALD-PCN program
will focus on the concepts of the Glycemic Index (GI) in
accordance with the Canadian Diabetes Association
Clinical Practice Guidelines [2]. The goal will be to in-
crease daily consumption of low-GI foods. Participants
will be encouraged to exchange high-GI foods with low-
GI foods (i.e. replace white or whole wheat bread with
pumpernickel) on at least 3 days/week and to make at
least 2 exchanges over the course of those days. Gly-
cemic index goals will be based on the Good-Better-Best
principle proposed by Brand-Miller and Foster-Powell
[26] which suggests a “this-for-that” exchange system
whereby low-GI foods are euphemistically termed lea-
kers (i.e., the “this”) should replace high glycemic index
foods termed gushers (i.e., the “that”) in the diet. Achiev-
ing high task self- efficacy for identifying low and high
glycemic index foods is considered an essential compo-
nent of this study. We have previously shown this ap-
proach increases general GI knowledge [27].
Program delivery training for exercise specialists
One Exercise Specialist (i.e., certified by the Canadian
Society of Exercise Physiology) will administer the inter-
vention at each PCN. A full day workshop for all special-
ist detailing the delivery of the HEALD intervention will
be organized and led by Dr. S. Johnson (developer of the
HEALD intervention). Dr. S. Johnson will also meet with
each Exercise Specialist at each PCN to review the
HEALD materials prior to the delivery of the first
HEALD group session. Study manuals that cover all
aspects of the HEALD intervention will be provided at
the training workshop.
Usual care
Participants in the usual care or “Off” group will receive
usual or standard care for diabetes from their family
physicians and/or chronic disease management team
based on clinical practice guidelines. Participants in
this group will be followed up for the same time
(i.e., 6 months) and will undergo all the assessments and
measurements as participants in the intervention group.
Study measures
We will use a combination of metrics to determine the
effectiveness of the HEALD-PCN. As in our HEALD
pilot study [23], the primary outcome is physical activity
determined by self- report and pedometers. Secondary
outcomes include nutrition behaviours (healthy eating
and glycemic index), anthropometric assessments, andbiomarkers. All primary and secondary outcomes will be
collected at baseline, 3 and 6 months, through surveys
and point of care instrument testing. Demographic,
health/medical and other related characteristics will also
be assessed at baseline, 3 and 6 months. At study com-
pletion, we will assess self-reported health status and
satisfaction with the intervention materials and ped-
ometers. We will also collect information on the cost
of this enhanced lifestyle program in the PCN environ-
ment and subsequent participant health care utilization,
through linkages with Alberta administrative data. To do
so, participants enrolled in the study will be asked for
permission to access their medical records by signing a
consent form and providing their personal health num-
ber, thus allowing linkage to Alberta Health and Wellness
physician billing, hospital billing, and emergency room
billing data. This linkage will allow health care utilization
and health care costs to be included in the evaluation.
Physical activity behaviours Our primary outcome is
self-reported physical activity, assessed with the Godin
Leisure Time Exercise Questionnaire (GLTEQ) [28],
modified to calculate MET minutes values [29] for total
moderate and vigorous physical activity. The GLTEQ
asks participants to report the average number of times
per week, in the past month, they engaged in vigorous
(rapid heartbeats, sweating), moderate (not exhausting,
light perspiration) and mild (minimal effort and no per-
spiration) intensity PA, for a minimum of 10 minutes
per session. Participant responses for the moderate and
vigorous activity categories will be added together to cal-
culate moderate and vigorous physical activity (MVPA)
minutes per week and will serve as our primary self-
report outcome measure.
For walking specific behaviors, pedometers (Yamax
SW-200) and step logs will also serve as an objective
measure of our primary outcome. Participants in both
the intervention and control groups will be provided
with a pedometer, and instructed to wear it and record
total daily step-counts in a log for 3 consecutive days in-
cluding one weekend day. The step log also allows for
the collection of brisk steps for the intervention group.
Self-reported walking will also be assessed using ques-
tions form the International Physical Activity Question-
naire (IPAQ) long version [30]. Participants will be
asked, “During the last 7 days on how many days did
you walk for at least 10 minutes at a time to go from
place to place” or “in your leisure time”. Participants will
then be asked, “How much time did you usually spend
on ONE of those days walking from place to place” or
“walking in your leisure time”. Responses will be
recorded in days, hours, and/or minutes per day. A
walking score will be calculated by multiplying the num-
ber of walking days by the walking minutes then by 3.3
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scores in MET-minutes. Stages of physical activity be-
haviour change measures (≥ moderate levels) initially
developed by Reed and colleagues [31] will serve as a
secondary behavioral outcome (to assess stage transition).
Clinical measures Using previously validated point of
care testing devices, participants will have fasting capil-
lary blood samples collected to assess hemoglobin A1c
(DCA Vantage), lipid profile, glucose (Cholestech LDX),
resting heart rate and blood pressure (BPTru). These
clinical measures will be taken at baseline, 3 and
6 months. Anthropometric measurements including
weight, height, and waist and hip circumference will be
completed and body mass index (BMI) calculated.
Other measures For nutrition behaviours, a validated
food frequency questionnaire [32] will be used to esti-
mate saturated fat, trans fat, total sugars, "added sugars"
(in sweetened cereals, soft drinks, and sweets), fruit and
fruit juice, vegetable intake, glycemic load and glycemic
index. Validated published measures of health related
quality of life [33-35], depressive symptoms using the
Patient Health Questionnaire-9 [36-38], problem areas
in diabetes [39], medication use, foot care, smoking be-
haviour, history of chronic diseases and risk factors [40].
Social cognitive variables related to physical activity
behaviors from protection motivation theory, theory of
planned behaviour, social cognitive theory, and stages of
change will also be examined at baseline, 3 and 6 months
using validated measures [41].
Implementation evaluation By applying the RE-AIM
Framework, our academic group and PCN partners are
highly engaged in facilitating an in-depth understanding
of the process variables necessary to inform the success-
ful future adoption and sustainability of this intervention
in similar primary care settings. The RE-AIM framework
provides a systematic means to evaluate the overall
population-based impact of an intervention and it’s po-
tential for translation through five components that
describe: Reach, Effectiveness, Adoption, Implementa-
tion, and Maintenance [42].
Unlike studies focused only on efficacy, the RE-AIM
framework emphasizes both internal and external valid-
ity while considering both individual and system level
outcomes [41]. It serves to prioritize public health issues
as it impacts real world settings, facilitating the transla-
tion of research into practice [42]. This framework has
been applied in the evaluation of several health behav-
iour change interventions, specifically those that target
physical activity, and diabetes [42-45]. The RE-AIM
framework has been incorporated into the HEALD im-
plementation and evaluation framework, through theuse of a logic model and data matrix, that outlines evalu-
ation questions, indicators and metrics, and data
sources.
Our proposed evaluation activities that will inform
dimensions of RE-AIM include systematic documenta-
tion of (a) usual care related to lifestyle counseling, (b)
PCN organizational factors and strategies, (c) readiness
and ability to implement HEALD through a checklist
and interview guide administered to the Executive
Directors, Chronic Disease Managers at each PCN, and
(d) implementation facilitators and barriers identified by
the Exercise Specialists. Data collected through the RE-
AIM framework serves several evaluative functions: 1)
determining the overall public health impact and trans-
latability/applicability, 2) comparing the intervention’s
public health impact across settings overtime, 3) com-
paring interventions across the various RE-AIM compo-
nents, 4) assisting in the decision-making process of
resource allocation for more effective programs, 5) pro-
viding information related to the level of implementation
across the stages of research, and (6) providing valuable
information to PCNs on the sustainability of long-term
behaviour change (at patient and organization/system
levels) beyond the intervention. All of these purposes
have been highlighted in the diabetes literature as essen-
tial components to progress the research base in behav-
iour change [42,45-47].
Qualitative follow-up To enhance to the validity of the
quantitative findings and provide further information on
the natural history (albeit retrospective) of the adoption
of positive health behaviours for self-management, 10%
of the participants (from each of the study groups at
each of the PCNs) will be randomly selected to partici-
pate in a structured qualitative telephone interview at
6 months following the completion of the HEALD inter-
vention. We hope to explicate their attitudes and beha-
viours related to the process of their healthy eating and
active living behaviour change (or lack there of ) and the
program components.
Analytic strategy
All statistical tests will be two-sided with a level of sig-
nificance set at 0.05 to evaluate the effectiveness of the
intervention. Baseline comparisons will be performed
using univariate analysis of variance (ANOVA) for con-
tinuous variables and chi-square analyses for categorical
variables. The main analysis of our study is to compare
the physical activity of the HEALD-PCN intervention
(On) group participants to the usual care (Off ) group,
from baseline to 6 months as our primary assessment
time-point. Employing the intention-to-treat (ITT) ap-
proach, we will also assess differences in group changes
from: (1) baseline to 3 months, (2) baseline to 6 months,
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mixed-model analysis (GLMM). GLMM uses all avail-
able data and provide a valid analysis when data are
missing at random. The models will use baseline values
for each outcome variable as a covariate to reduce the
residual standard error and account for regression to the
mean. Potential confounding variables (i.e., age, sex and
BMI) will be included as covariates in the models. All
data will be analyzed using Statistical Package for the So-
cial Sciences v.20, SPSS Inc., Chicago Illinois, USA and
Stata SE 10.1, StatCorp, College Station, Texas, USA.
Based on the study’s design, we will account for 2
measurement points for the main dependent outcome
(i.e., physical activity behavior at 6 months) across the
study groups. In a 2 time-point, 2 group, repeated mea-
sures design with an a priori fixed and random effects
model set to detect a moderate effect size (f = 0.25) while
assuming a modest correlation (r = 0.5), the required
sample size is 86 participants per group (power = 0.90;
alpha = 0.05) [48-50]. Sample size was also estimated at
75 participants per group for average steps per day as-
suming an increase of 1,750 steps; that is, 8,250 versus
6,500 ± 3,300 steps/day for the intervention group over
the control respectively (power = 0.90; alpha = 0.05). Our
sample size estimate for our primary outcome is also
sufficiently powered to detect a clinically meaningful dif-
ference between the groups of 0.5% for HbA1c assuming
a baseline HbA1c of 7.2 ± 1.2%. This baseline estimation
of HbA1c was derived from data provided by the
Alberta Diabetes Surveillance System [17]. Given the
length of follow-up period, we conservatively estimate
that the rate of attrition during the intervention could
reach 20% [51], and so our sample size was increased to
110 per group to account for the possibility of loss to
follow-up.
Discussion and conclusions
We have described the rationale and design of a trial that
is pragmatic and applicable to examine the effectiveness
and efficiency of a population-based strategy for two im-
portant components of chronic disease management
among adults with T2DM. The HEALD-PCN intervention
is a relevant approach to diabetes management, although
some might argue that a self-management study for
T2DM is not a novel intervention and that there is suffi-
cient evidence for clinical improvements among this
population after participating in an self-management
interventions - we would agree. What is novel about this
study is the implementation of the program in a “real
world” setting, and by expanding the typical inter-
disciplinary nature of the “diabetes team”; that is, partici-
pants will be recruited from primary care clinics in differ-
ent areas of Alberta and Exercise Specialists who are now
becoming more a part of the primary care diseasemanagement team, will deliver the program in routine
care as it might be offered if not part of a research study.
Moreover, we have established partnerships between a
model for health care delivery (i.e., PCN) and a local
resource (i.e., community recreation facility) that should
support the achievement of some of the behavioural and
clinical targets of diabetes management. This study
will provide new information around clinical- and cost-
effectiveness in the context of everyday primary care and
thus it will significantly add to the current literature in
health service delivery for diabetes self-management.
The broader evaluation using the RE-AIM framework
will produce timely and meaningful data for policy
makers and health care providers interested in ques-
tions around the implementation and sustainability of
this type of program. Having described the strengths of
the current study, we also acknowledge the limitations
of the HEALD-PCN study. First, although the design
for the evaluation of HEALD-PCN is applicable from a
health system delivery perspective (i.e., recruiting from
patient registries to simulate regular patient invitations
to PCN programs), it still remains a weaker design than
a formal randomized controlled trial. Nevertheless,
there is a need for pragmatic studies of this type, as
questions related to the external validity should now
take precedence over concerns of internal validity (i.e.,
the efficacy of the intervention has already been estab-
lished) [18,52,53]. Second, as is often found in con-
trolled quality improvement studies, the definition of
usual care for the management of T2D is rather vague.
For this study usual care may not reflect usual care in
other primary care settings. To help answer any ques-
tions with respect to usual care in this setting, we will
be collecting information from a system capacity per-
spective and from a patient perspective. As a result of
the expected heterogeneity of usual care across the
PCNs in this study, the generalizability of the findings
will have to be contextualized to the individual PCNs if
there are indeed substantial differences in what is
deemed usual care. Nevertheless, the implementation
of the study in four separate primary care settings
allows for broader, comprehensive understanding with
respect to issues of program effectiveness, applicability,
feasibility and context. It is recognized that the cur-
rently available body of knowledge around this type of
investigation handcuffs health policy makers and care
providers when developing and initiating evidence-
informed policies for new and existing health technolo-
gies and interventions [52-54].
In summary, healthy eating and active living remain
cornerstones of T2DM management. Since the global
prevalence of T2DM is expected to increase beyond
previous estimates, best practices for promoting these
self-management cornerstones at a population level are
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results of this study may provide valuable information re-
lating to the implementation of other physical activity-
based chronic disease prevention and management
interventions.
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